One2Treat’s Post

👨🔬 Dive into the world of decentralized clinical trials with our very own, John Valenta, PhD! At the recent conference in Savannah, GA, experts discussed virtual trial operations and remote study requirements. Thanks to the Optum Center for Research and Innovation (OCRI), Dr. Valenta delved into cutting-edge research methodologies.

“Before Fourwaves, my inbox was chaos.” Annick Guyot, Ph.D., Coordinator for the Centre de recherche en biologie structurale (CRBS) and Manager at the Cystic Fibrosis Translational Research Centre (CFTRc), juggled multiple research events each year. With endless emails about registrations, abstract submissions, and committee communications, staying organized felt impossible. That all changed in 2013 when Annick discovered Fourwaves. "Now it’s all in one place, and staying on top of things is easy. Fourwaves saves me so much time." Since adopting Fourwaves a decade ago, McGill University has hosted a dozen of well-organized events for groundbreaking research in structural biology and cystic fibrosis. Whether in-person or virtual, Fourwaves helps Annick’s teams focus on what truly matters: advancing research and fostering collaboration. If Fourwaves can transform events at McGill, imagine what it can do for your institution. Create your free custom event website in under 2 minutes here: https://lnkd.in/ektppUnU

Last week, Holger Senn presented at the PTC European Life Science Exchange event, discussing "AI in Variant and Configuration Lifecycle Management (CLM) of Medical Devices," with a focus on mastering complexity related to regulations and compliance. Holger presented the benefits medical device manufacturers can achieve using a CLM approach, including: - Standardizing processes - Capturing knowledge - One consistent data model Learn more about the benefits of a CLM approach by visiting https://lnkd.in/e8kzsktY #medicaldevice #manufacturing #complexitymanagement  

🛣️ Pioneering progress in clinical trials: We’re proud to spotlight the incredible work of our team at the 7th International Clinical Trials Methodology Conference (ICTMC) in Edinburgh! With 15 presentations selected, our team showcased cutting-edge advancements across diverse areas of clinical trials. Including public engagement, study design, data management, technology innovations, and statistical methodologies. In this recently published article, hear from Kenan Direk, and Arzish Haqqee about their experiences of presenting at the conference. Their reflections highlight the collaborative and innovative spirit that drives our work. Read the full article via the link in the comments ⬇️

Getting the word out about a resource is not easy! No one wants to create something that could help people, only to have it sitting passively on a website. That's why the Clinical Research Glossary team at the Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard (MRCT Center) is hosting another webinar on June 4th at 11 AM ET focused on: - lots of different ways that organizations across the research ecosystem have taken action to implement the Clinical Research Glossary; - inviting people from different communities and backgrounds to share their feedback on new Clinical Research Glossary definitions in June. I'll be joined by Sophia Zilber 🌺, Amy Mirabella PhD, RN, CHPN, Claudine Moore, and Holly Parker, all sharing their experiences. Clear communication about clinical research helps build industry trustworthiness and challenges misconceptions about science. Please join us and share, to help grow the glossary, and reach more people, organizations, and companies with this resource. You can register here:

Building trust is a process that requires intentionality, authenticity, humility, and a willingness to reexamine institutional norms and narratives. Melissa Tribelhorn, MPA and Northwest Association for Biomedical Research are providing critical thought leadership on an important frontier at the intersection of healthcare and technology to weigh the benefits and risks of rapid technological advancement in patient data acquisition and the potential impact on a range of products from consumer healthcare devices to breakthrough therapeutic discoveries. I deeply appreciate the approach through a critical policy lens - ie. how can we create an environment that propels new innovation while being mindful of maintaining sensible guardrails along the way?

We are thrilled to introduce the Scientific Committee for the 12th International Lymphoedema Conference: David Keast, Co-Chair (Canada) Jane Armer, Co-Chair (United States) Christine Moffatt (United Kingdom) Susan Nørregaard (Denmark) Ad Hendrickx (Netherlands) Isabelle Quéré (France) Melanie Thomas (Wales) Nele Devoogdt (Belgium) Arthur Bagonza (Uganda) Saravu Narahari (India) Sandro Michelini (Italy) This expert committee of global professionals is dedicated to advancing research, improving treatments, and raising awareness of lymphedema. Their commitment to scientific excellence will play a pivotal role in shaping the conference program. We are also excited to welcome the Scientific Committee as presenters on vital topics ranging from secondary lymphedema, to the latest research and treatment methods to primary lymphedema, genetics, data collection and lymphedema in low resource settings. Whether you're a patient, healthcare professional, researcher, or advocate, the conference will offer presentations tailored to your interests, providing a valuable and enriching learning experience. Learn more at buff.ly/47Znsoy #ILF2025 #canadalymph #lymphedema #lymphedemaconference

At last night’s 15th Annual DSF Research Roundtable, we announced the 2024 DSF Grant Awards recipients. With over 150 researchers, medical professionals, and industry partners in attendance, the evening highlighted the collective effort driving progress in Dravet syndrome research. This year, $1.4M in funding will support five projects focused on addressing the underlying cause of Dravet syndrome. These grants reflect years of collaboration and scientific progress, and we are proud to support research that moves us closer to better treatments and outcomes for families. Learn more about the 2024 grant recipients and their work: https://bit.ly/3Vt1dCq

BBMRI-ERIC-nl at the symposium for ELSI insights & outlook for biobanks and medical research: Earlier this month BBMRI-nl took part in the Symposium for Ethical, Legal and Societal Insights (ELSI) & outlook for biobanks and medical research in Lyon, co-organised by BBMRI-ERIC. The symposium brought together #ELSI and biobank experts from across Europe and even abroad.     From BBMRI-nl, a representative from the national ELSI Servicedesk and Health-RI ELSI team participated. Miriam Beusink provided insight into the Dutch consent procedures for reusing health data and samples in research: the current situation, showcasing the broad consent of the Netherlands Cancer Institute and diving into the potential bias this is causing, as well as Health-RI's desire to create a national consent registry. Other discussed topics were the #EHDS, the importance of knowing the context of the data for responsible secondary use, the importance of being able to clearly communicate with patients and citizens, trust, anonymity, return of results and incidental findings, and problems around data integration and large data infrastructures.  The Dutch node (BBMRI-nl) of the European Research Infrastructure BBMRI is hosted by Health-RI. For more information visit https://lnkd.in/eDD9ruid

Healthcare science colleagues and system diagnostic leads along with other interested professionals from across the region came together for the launch of the Midlands Physiological Science Network. The day provided an opportunity to foster collaboration, innovation, and excellence in physiological science across the Midlands region. Read more: https://lnkd.in/eDR9ySnb